Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine.

Belongia EA, Irving SA, Shui IM, Kulldorff M, Lewis E, Yin R, Lieu TA, Weintraub E, Yih WK, Li R, Baggs J; Vaccine Safety Datalink Investigation Group.

Pediatr Infect Dis J. 2010 Jan;29(1):1-5. doi: 10.1097/INF.0b013e3181af8605.

PMID:
19907356
2.

Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007.

Haber P, Patel M, Izurieta HS, Baggs J, Gargiullo P, Weintraub E, Cortese M, Braun MM, Belongia EA, Miller E, Ball R, Iskander J, Parashar UD.

Pediatrics. 2008 Jun;121(6):1206-12. doi: 10.1542/peds.2007-3793.

PMID:
18519491
3.

An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?

Haber P, Chen RT, Zanardi LR, Mootrey GT, English R, Braun MM; VAERS Working Group.

Pediatrics. 2004 Apr;113(4):e353-9.

PMID:
15060267
4.

Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2007 Mar 16;56(10):218-22.

5.

Rotavirus live, oral, pentavalent vaccine.

Tom-Revzon C.

Clin Ther. 2007 Dec;29(12):2724-37. doi: 10.1016/j.clinthera.2007.12.018. Review.

PMID:
18201590
6.

Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.

Laserson KF, Nyakundi D, Feikin DR, Nyambane G, Cook E, Oyieko J, Ojwando J, Rivers SB, Ciarlet M, Neuzil KM, Breiman RF.

Vaccine. 2012 Apr 27;30 Suppl 1:A61-70. doi: 10.1016/j.vaccine.2011.09.026.

PMID:
22520138
7.
8.

RotaTeq vaccine adverse events and policy considerations.

Geier DA, King PG, Sykes LK, Geier MR.

Med Sci Monit. 2008 Mar;14(3):PH9-16.

PMID:
18301365
9.

Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system.

Zanardi LR, Haber P, Mootrey GT, Niu MT, Wharton M.

Pediatrics. 2001 Jun;107(6):E97.

PMID:
11389295
10.

Active surveillance of vaccine safety: a system to detect early signs of adverse events.

Davis RL, Kolczak M, Lewis E, Nordin J, Goodman M, Shay DK, Platt R, Black S, Shinefield H, Chen RT.

Epidemiology. 2005 May;16(3):336-41.

PMID:
15824549
11.

Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception.

Bines JE, Patel M, Parashar U.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S282-90. doi: 10.1086/605051.

PMID:
19817611
12.

Risk of intussusception after monovalent rotavirus vaccination.

Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, Klein NP, Glanz JM, Jacobsen SJ, Naleway A, Jackson LA, DeStefano F.

N Engl J Med. 2014 Feb 6;370(6):513-9. doi: 10.1056/NEJMoa1311738. Epub 2014 Jan 14.

13.

The pentavalent rotavirus vaccine, RotaTeq.

Matson DO.

Semin Pediatr Infect Dis. 2006 Oct;17(4):195-9. Review.

PMID:
17055370
14.

Intussusception and rotavirus vaccination: a review of the available evidence.

Patel MM, Haber P, Baggs J, Zuber P, Bines JE, Parashar UD.

Expert Rev Vaccines. 2009 Nov;8(11):1555-64. doi: 10.1586/erv.09.106. Review.

PMID:
19863248
15.

Evaluating the safety of a rotavirus vaccine: the REST of the story.

Heyse JF, Kuter BJ, Dallas MJ, Heaton P; REST Study Team.

Clin Trials. 2008;5(2):131-9. doi: 10.1177/1740774508090507.

17.

Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program.

Carlin JB, Macartney KK, Lee KJ, Quinn HE, Buttery J, Lopert R, Bines J, McIntyre PB.

Clin Infect Dis. 2013 Nov;57(10):1427-34. doi: 10.1093/cid/cit520. Epub 2013 Aug 26.

18.

Underestimates of intussusception rates among US infants based on inpatient discharge data: implications for monitoring the safety of rotavirus vaccines.

Cortese MM, Staat MA, Weinberg GA, Edwards K, Rice MA, Szilagyi PG, Hall CB, Payne DC, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S264-70. doi: 10.1086/605055.

PMID:
19817607
19.

Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.

Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, Hambidge SJ, Glanz JM, Klein NP, Weintraub E.

JAMA. 2012 Feb 8;307(6):598-604. doi: 10.1001/jama.2012.97.

PMID:
22318281
20.

Intussusception surveillance in a rural demographic surveillance area in bangladesh.

Zaman K, Breiman RF, Yunus M, Arifeen SE, Mahmud A, Chowdhury HR, Luby SP.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S271-6. doi: 10.1086/605047.

PMID:
19817608

Supplemental Content

Support Center